September 8, 2025 | We’re excited to share a new interview with Pam & Chris Andrews in RARE Revolution Magazine. A huge thank you to Nicola Miller for capturing our story so beautifully.
The article highlights the impact of cyclodextrin (also known as adrabetadex or vts270) for patients with NPC, a form of childhood dementia—and underscores why it’s critical to begin treatment as early as possible, before symptoms appear.
We’re grateful to RARE Revolution Magazine for helping shine a light on the importance of newborn screenings and for sharing our rare journey.
Read the full interview.
